Pandey Rajeev Kumar, Bhatt N N, Singhala T M, Shukla V D
Ph.D Scholar, Department of Panchakarma, National Institute of Ayurveda, Jaipur, Rajasthan, India.
Ayu. 2011 Oct;32(4):536-9. doi: 10.4103/0974-8520.96129.
In the present study, Vamana and Virechana along with palliative treatment was given to patients of Sthula Prameha (Diabetes mellitus or DM). An attempt was made to compare and evaluate the role of Shodhana therapy (Vamana and Virechana). Total 47 patients of Sthula Pramehi were registered in this study, out of which 38 completed the treatment. The patients were divided into two groups, viz. Vamana with Shamana (Group A) and Virechana with Shamana (Group B). Eighteen patients completed the treatment in Group A and 20 in Group B. Neem giloy satva capsule was used as Shamana drug at a dose of 500 mg twice daily after meals for 30 days in both the groups. The efficacy of therapy was assessed based on relief in cardinal signs and symptoms and blood sugar, lipid profile and other biochemical parameters etc. The results showed that the Vamana provided better relief in signs and symptoms as well as on fasting blood sugar (FBS) and postprandial blood sugar (PPBS) in comparison to Virechana.
在本研究中，对患有“stula Prameha”（糖尿病或DM）的患者给予催吐和泻下疗法以及姑息治疗。尝试比较和评估净化疗法（催吐和泻下）的作用。本研究共登记了47例“stula Pramehi”患者，其中38例完成了治疗。患者被分为两组，即催吐结合调和（A组）和泻下结合调和（B组）。A组有18例患者完成治疗，B组有20例。两组均使用印楝吉尔洛依散胶囊作为调和药物，剂量为500毫克，每日两次，饭后服用，持续30天。根据主要体征和症状的缓解情况以及血糖、血脂谱和其他生化参数等来评估治疗效果。结果表明，与泻下疗法相比，催吐疗法在体征和症状以及空腹血糖（FBS）和餐后血糖（PPBS）方面提供了更好的缓解。
